Similar Articles
431 Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis
432 Latamoxef-induced severe thrombocytopenia during the treatment of pulmonary infection: A case report
433 Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
434 Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
435 Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
436 Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
437 Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
438 Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease
439 Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection
440 miR-3682-3p directly targets FOXO3 and stimulates tumor stemness in hepatocellular carcinoma via a positive feedback loop involving FOXO3/PI3K/AKT/c-Myc
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA